Our
News.

Find here announcements, activities within the consortium, and activities for the public.

Open Community Day | Beyond Gravitate Health: bringing patient friendly ePI into the real world

Conclusion of Gravitate Health project is approaching. Initially a five-year project, Gravitate Health was extended to another 8 months until June 2026. We are delighted to announce that the project outputs are going to be presented at the Our Open Community Day on June 4th, at Steigenberger Icon Wiltcher's Hotel in Brussels.
Gravitate Health extends an invitation to all involved in the project; contributors from collaborating projects, or stakeholders aligned with Gravitate Health’s mission to:
  • be introduced to Gravitate Health’s main outputs and contributions;
  • find out about Gravitate Health next steps; future actions towards sustainability;
  • join the Panel Discussion “Bringing Patient-friendly ePI to life.”
Registration is required, to secure your participation. Registration is free of charge.

CLOSING CONFERENCE | OPEN COMMUNITY DAY

WHEN? June 4th, 2026 | 09:00 – 14:00

WHERE? Steigenberger Icon Wiltcher’s Hotel Brussels, Belgium & virtually

AGENDA ANNOUNCED!

09:00 | Welcome – greetings

  • Opening remarks – Niklas Blomberg, IHI CEO
    The origins of Gravitate Health – an industry and public perspective
  • “GRAVITATE CENTER FOR TRUSTED HEALTH INFORMATION” – Launch – Introducing the Gravitate Health post-project sustainability activity project, led by University of Oslo

10:00 – 11:30 | Gravitate Health outcomes and contributions – next steps delivered upon project ambition

  1. Scene setting; ambition, landscape and achievements
  2. Project achievements
    1. Demonstrating the G-lens ‘Minimal Viable Product’
    2. Information services and standards development
    3. Change Agency – community interest and regional/global engagement
  3. Project Impact across the value chain
    1. Access to and understanding of health information
    2. Creation of solutions
    3. Validation – testing scenarios
  4. Guidance – ‘realistic strategies for the use of ePI’ – White Paper

11:30 – 12:15 | Networking and Refreshments – snacks

12:15 – 13:45 | Panel discussion: “Bringing Patient Friendly ePI to life – beyond Gravitate Health

Moderators: Dr. Giovanna Ferrari, Pfizer; Prof. Anne Moen, University of Oslo

Panelists bringing different stakeholder views:

Patients            Jane Giudice, Gravitate Health User Advisory Group Member-EPF, EULAR Patient Research Partner, EUPATI Fellow and EUPATI Alumni Network Steering Committee Secretary

Regulators          Amparo Revuelta, European Medicine Agency

Policy                   Anthony Rodiadis, EU Policy Officer

IATF                      Koen Nauwelaerts, IATF co-chair, Bayer

Industry               Rupen Mehta, PA Consulting

Pharmacists       Ilaria Passarani, PGEU

Compendia        Bente By Janssen, Felleskatalogen

13:45 – 14:00 | Summing up – adjourn

Gravitate Health’s valuable outputs in a nutshell
Gravitate Health project set out to fulfill an ambitious mission, to empower and equip Europeans with Health Information from trusted sources, for active, personal health management and adherence to treatment, starting with ePI. During its lifetime the project can showcase a number of valuable outputs which will be discussed at the Closing Conference:
  • The development of G-lens®, a digital tool that provides a more personalized presentation of electronic Product Information (ePI) by tailoring medication leaflets to an individual’s specific needs based on their personal health data, preferences and context of use.
  • Content Focusing Mechanism: With the G-lens® the project demonstrated mechanisms to highlight essential medication information for the user, making complex regulatory labels easier to navigate and understand.
  • Global Standard Advancement: The project has been instrumental in driving the creation and adoption of the global HL7 FHIR ePI standard, in full alignment between the European Medicines Agency (EMA) and ready for global use as the VULCAN ePI profile.
  • ISO IDMP Integration: Gravitate-Health leverages and contributes to ISO IDMP (Identification of Medicinal Products) standards to leverage international interoperability and ensure accurate product identification across different healthcare systems and markets.
  • Multilingual Access: A major output is providing medicine information in a citizen’s language of choice, which is critical for patient safety and understanding, and useful for cross-border mobility within Europe.
  • Minimum Viable Products (MVPs): The project has delivered functional MVPs that demonstrate how personalized health information from trusted sources can drive medication adherence and patient safety. Moreover, to ensure long-term use across Europe, the project integrates its focusing mechanisms into existing digital health systems, such as the Danish medication card or Portugues SN24, eliminating the need for citizens to download separate applications.
Gravitate Health created a broad stakeholder ecosystem: operating as a public-private partnership with 45 partners across 16 European countries and the USA, the project collaborated with regulatory bodies like the EMA and FDA, with the pharmaceutical industry, information content providers, standards organizations, academia, and patient organizations to drive global standard adoption. Join the Open Community Day at our Closing Conference and find out more about the next day after the project conclusion.

Related Posts